Connective Tissue Motion Measure
CTMM1
Feasibility Study of Connective Tissue Motion Measure - a Biomarker for Perimuscular Connective Tissue Pathology.
2 other identifiers
observational
39
1 country
1
Brief Summary
The goal of this project is to develop a biomarker - the Connective Tissue Motion Measure (CTMM) -quantifying the functional behavior of perimuscular connective tissues.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 9, 2011
CompletedFirst Posted
Study publicly available on registry
August 10, 2011
CompletedAugust 10, 2011
August 1, 2011
3 months
August 9, 2011
August 9, 2011
Conditions
Study Arms (2)
Chronic Low Back Pain
No Low Back Pain
Eligibility Criteria
Community Sample
You may qualify if:
- history of recurrent or chronic LBP for a minimum of 12 months
- ability to stand and walk without assistance
- ability to understand and read English
- ability to understand and sign a consent form
- no history of low back pain or any other chronic pain that has limited activities of daily living or work
- a numerical current pain index of less than 0.5.
You may not qualify if:
- previous severe back or low extremity injury or surgery
- major structural spinal deformity (scoliosis, kyphosis, stenosis)
- ankylosing spondylitis or rheumatoid arthritis
- neurological deficit (weakness and/or sensory loss, decreased deep tendon reflexes suggesting nerve root compression, but not subjective symptoms of nerve root irritation (sciatica)
- neurological or major psychiatric disorder
- bleeding disorders
- corticosteroid or anticoagulant medication
- pregnancy
- worker's compensation or disability case
- in litigation for the LBP problem
- acute systemic infection
- BMI less than 21 or greater than 35
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stromatec, Inc.
Burlington, Vermont, 05401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 9, 2011
First Posted
August 10, 2011
Study Start
April 1, 2011
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
August 10, 2011
Record last verified: 2011-08